Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

195.22 +6.20 (+3.28%)
Official Closing Price Updated: 4:10 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,081,394
Open 189.92
Bid (Size) 194.90 (1)
Ask (Size) 195.99 (3)
Prev. Close 189.02
Today's Range 189.78 - 197.06
52wk Range 163.81 - 218.66
Shares Outstanding N/A
Dividend Yield 3.36%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Outlook: AbbVie Through The Eyes Of 4 Analysts
 
Via Benzinga
Why AbbVie Stock Flew Higher on Friday
A solid quarterly earnings report reverberated though the pundit community that day. 
Via The Motley Fool

Performance

YTD
+8.8%
+8.8%
1 Month
+2.8%
+2.8%
3 Month
+1.0%
+1.0%
6 Month
+11.1%
+11.1%
1 Year
+5.3%
+5.3%

More News

Read More
Discover which S&P500 stocks are making waves on Friday.
Via Chartmill
AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion
Via Benzinga
Topics Earnings
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
Via Benzinga
Topics Economy
Earnings Scheduled For July 31, 2025
Via Benzinga
A Peek at AbbVie's Future Earnings
Via Benzinga
Deal Dispatch: MEG Bidding War Heats Up, L Catterton Takes Bite Out Of Kisshokichi, Sunnova's Still Shining
Via Benzinga
5 Dividend Stocks With Solid Returns And More Growth Ahead
Via Benzinga
Why AbbVie (ABBV) Stock Is Up Today
Via StockStory
3 Dividend Healthcare Stocks to Buy Hand Over Fist Before They Double
Via The Motley Fool
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Via Benzinga
Topics Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Why AbbVie Stock Slumped Today
Via The Motley Fool
Topics Government
AbbVie Stock Eyes Breakout as Pipeline and Profits Grow
Via MarketBeat
AbbVie Lifts Outlook, Eyes Parkinson's Assets As Next Growth Frontier
Via Benzinga
AbbVie CEO Sees ‘Substantial Momentum’ For Remaining Year After Q2 Earnings Beat: Retail’s No Longer Pessimistic
Via Stocktwits
Topics Intellectual Property
AbbVie Inc (NYSE:ABBV) Beats Q2 2025 Earnings and Revenue Estimates, Raises Full-Year Guidance
Via Chartmill
AbbVie’s (NYSE:ABBV) Q2: Beats On Revenue
Via StockStory
AbbVie Retail Traders Remain Wary Amid Report Of $1B Gilgamesh Deal To Boost Mental Health Pipeline
Via Stocktwits
Topics Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Topics Intellectual Property
AbbVie (ABBV) Reports Q2: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
Eli Lilly’s Cancer Drug Demonstrates Better Effectiveness Than AbbVie’s In Late Stage Trial: Retail Believes In Holding The Stock
Via Stocktwits
Why Is ATAI Life Sciences Stock Trading Lower On Monday?
Via Benzinga

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 195.22
When was AbbVie last traded?
The last trade of AbbVie was at 08/01/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.